Any NYT reader looking at the buzzy front page headline below would immediately think that Robert F. Kennedy Jr. is a madman. Can he really be an advocate for repealing the polio vaccine, a disease ...

Axsome Therapeutics (NASDAQ:AXSM) has received FDA approval for its drug Symbravo for the acute treatment of migraine with or ...

Did this biotech company deliver the goods for investors? Let's see what a $1,000 investment would be worth. The post $1,000 ...

Polio, a disease that can cause lifelong paralysis, has been eliminated from the U.S. Experts fear a resurgence if lifesaving ...

Montelukast does not appear to increase the risk for neuropsychiatric adverse events in children and adolescents, according to a study published in JAMA Pediatrics. Montelukast is a leukotriene ...

The Trump administration is poised to supercharge America’s appetite for supplements.

Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...

The Food and Drug Administration’s approval of low-risk tobacco pouches is welcome, but why did it delay for more than four ...

Frito-Lay recalls over 6,000 bags of Lay's Classic Potato Chips due to undeclared milk, posing serious health risks.

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.

In early January it was revealed that Walmart's washed and ready-to-eat 12 oz. Marketside Broccoli Florets were voluntarily ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...